Home › NPS Pharmaceuticals Receives Orphan Drug Designation for Natpara in Europe
 

Keywords :   


NPS Pharmaceuticals Receives Orphan Drug Designation for Natpara in Europe

2014-01-04 07:51:40| Biotech - Topix.net

NPS Pharmaceuticals, Inc. , a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the European Commission has granted orphan drug designation to Natpara for the treatment of hypoparathyroidism.

Tags: europe drug receives designation

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
25.11adidas BECKENBAUER
25.11KISS DVD
25.1116
25.113
25.11HiHi Jets DVD CRUSH THE FRONTLINE
25.11SnowMan I DO ME
25.11m.u
25.11ICLS5& 2022
More »